Study Stopped
Enrollment closed due to impending graduation from Fellowship
Safety of Immediate Skin-to-Skin Contact After Vaginal Birth in Vigorous Late-Preterm Neonates
1 other identifier
interventional
47
1 country
1
Brief Summary
Late-preterm neonates are born between 34 and 36 weeks 7 days gestational age (GA). Neonates born less than 34 weeks GA are at increased risk for morbidity and directly admitted to the Neonatal Intensive Care Unit (NICU). Skin-to-skin contact (SSC) is a standard of care in many units to aid in post-natal transitioning. Current guidelines published by the Neonatal Resuscitation Program (NRP) and American Academy of Pediatrics (AAP) recommend only "vigorous, term" neonates initiate immediate SSC. There is no published data regarding safety or guidelines relating to late-preterm neonates and immediate SSC. Therefore, the investigators hypothesize that post-natal transitioning after immediate SSC within the first hours after birth will be no worse for vigorous, singleton 35 0/7 to 36 6/7 week neonates compared to those who transition to SSC after an initial period of 20 minutes observation under the radiant warmer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2017
CompletedFirst Submitted
Initial submission to the registry
June 29, 2018
CompletedFirst Posted
Study publicly available on registry
July 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedMay 3, 2019
May 1, 2019
1.2 years
June 29, 2018
May 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Skin-to-skin interruptions
The investigators will track the number of times skin-to-skin contact is disrupted within the first hour of life and document reasons for interruption.
First hour of life
Secondary Outcomes (1)
Risks for late-preterm neonates
Length of hospital stay
Study Arms (2)
Skin Group
EXPERIMENTALPulse oximeter probe is placed on right wrist of vigorous neonate after vaginal birth. If randomized to skin group, neonate will initiate skin-to-skin contact after umbilical cord is cut and dried with warm blankets on Mother's abdomen. Length of monitoring will be for first hour of life.
Warmer Group
ACTIVE COMPARATORPulse oximeter probe is placed on right wrist of vigorous neonate after vaginal birth. If randomized to warmer group, neonate will initiate skin-to-skin contact after 20 minutes of observation under the radiant warmer. Length of monitoring will be for first hour of life.
Interventions
1. If the newborn is vigorous (crying, good respiratory effort, good tone) after vaginal delivery, newborn will be able to go directly to Mother's chest for immediate SSC 2. A pulse oximeter will be placed on the newborn's right wrist. Saturations will be monitored on a pulse oximeter located next to the Mother's bed for the first hour of life.
1. Newborn will go to the radiant warmer, pulse oximeter placed on newborn's right wrist, and saturations will be monitored on the Panda Warmer. 2. If stable per Baby RN after 20 minutes of observation, the newborn will be placed on Mother's chest for SSC. Vital signs will be monitored for the first hour of life.
Eligibility Criteria
You may qualify if:
- Singletons born 35 0/7 to 36 6/7 weeks GA via vaginal delivery
- Vigorous - crying, good respiratory effort, good tone
- No major congenital malformation
You may not qualify if:
- Neonates born \< 35 weeks GA
- Non-vigorous or needing resuscitation soon after birth
- Known major congenital malformation
- Maternal sedation or if clinically unstable per Labor \& Delivery team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UH Cleveland Medical Center
Cleveland, Ohio, 44106, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Monika Bhola, MD
UH Cleveland Medical Center MacDonald Women's Hospital
- PRINCIPAL INVESTIGATOR
Rebecca Walsh, MD
UH Cleveland Medical Center MacDonald Women's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neonatology Fellow, MD
Study Record Dates
First Submitted
June 29, 2018
First Posted
July 12, 2018
Study Start
November 8, 2017
Primary Completion
January 31, 2019
Study Completion
May 1, 2019
Last Updated
May 3, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share